December 12, 2011 |
Medication to treat ocular hypertension may drastically cut the frequency of developing a common form of glaucoma, a study finds. A letter released today in the journal Archives of Ophthamology reports on a study of 1,636 people who were randomly assigned to a group that received medical treatment for ocular hypertension or to a group that was observed. After following up with the groups for an average 7.5 years, the observation group was offered medication, and both groups were followed again for an average 5.5 years.
August 9, 2011 |
More frequent visual tests for glaucoma patients could allow physicians to better follow the condition's progression, a study finds. A study released online Monday in the Archives of Ophthamology examined data on 468 eyes of 381 patients age 35 to 80 who were part of a long-term intervention study. The participants had primary open-angle glaucoma no longer being controlled by medication. This type of glaucoma is the most common form and usually hits people over 50. It causes damage to the optic nerve and usually progresses slowly, sometimes without being noticed.
December 7, 2009 |
Taking a prescription drug for a cosmetic side effect -- at the risk of other side effects -- may seem risky. But it's a risk that many Americans, mostly women, have shown themselves happy to take. Latisse, originally a glaucoma drug marketed under the name Lumigan, was approved separately at the end of last year for its eyelash-enhancing purposes, and its maker, Allergan, has reported sales of $47.7 million thus far. The company says 2009 sales could reach $70 million, exceeding projections of $30 million to $50 million.
CALIFORNIA | LOCAL
June 28, 2009 |
A nubby black cloth covers the sole window in Frank Lucero's Hemet living room, casting a perpetual dusk over his refuge, a space as cramped as the prison cells where he spent a decade. He can't bear the light. Even an overcast day on the sprawling range shadowed by the San Jacinto Mountains brings on headache, dull pain in his right eye and ghostly sensations in the empty socket of his left.
December 4, 2008 |
Federal regulators said a glaucoma drug from Allergan Inc. appears to make eyelashes longer and fuller, and experts soon will assess the safety of that new use. The Irvine company has asked the Food and Drug Administration to approve its bimatoprost formula to enhance eyelashes. On Friday a panel of experts will comment on the drug's safety and effectiveness as a cosmetic. The drug is already marketed under the name Lumigan to treat eye conditions stemming from glaucoma. In studies for that treatment, researchers first noticed the drug seemed to stimulate eyelash growth.
June 29, 2008 |
The governors of New York and Oregon are doing fine after each underwent surgery. New York Gov. David Paterson had a successful cataract surgery, spokeswoman Erin Duggan said, and planned to resume his normal schedule today. Paterson, 54, is legally blind. The cataract was discovered during a procedure last month to relieve pain from acute glaucoma. Oregon Gov. Ted Kulongoski, 68, planned to leave Salem Hospital today after having his gall bladder removed, said spokeswoman Anna Richter Taylor.